Revvity, Inc. (RVTY) stock price, quote and key numbers

Updated 28 September 2026, 09:52 ET

Revvity, Inc. (RVTY) closed at $151.11 on 25 September 2026, up 0.3%. That leaves it up 5.3% over a week, up 19.6% over a month and up 78.8% over a year. It is at the top of its 52 week range of $81.22 to $152.26. The median analyst price target of $120 sits 20.6% below the close.

The price

Changes compare dividend and split adjusted closes over trading sessions, so the one year figure is the last close against the close 252 sessions earlier. The 52 week range uses the daily highs and lows of the same window. Read the guide: How to read a stock quote.

The live price, the day's chart and the pre market and after hours prints are in the app: open RVTY in Just Stock Quotes.

Trend and range

RVTY trades above both its 50 day average of $123.69 and its 200 day average of $105.00, the shape of an uptrend. The 50 day average sits above the 200 day average. Its beta against the S&P 500 over the last year is 1.15, a stock that moves more than the market. It is 0.8% below its 52 week high and 86.1% above its 52 week low.

Moving averages smooth the closes of the last 50 and 200 sessions; being above or below them describes the trend, it does not predict it. Beta is how much the stock moved for each move in the S&P 500 over the year. Read the guide: Moving averages, the 52 week range and beta.

What analysts say

In the last 90 days 4 firms recorded 5 actions on RVTY: 3 kept a view and 2 new initiations. Price targets: 4 raised. The most recent targets from 11 firms run from $90 to $165, with a median of $120, 20.6% below the last close.

A target is one firm's guess at the price a year out, and the average runs optimistic. The useful reading is the mood: high targets and a wall of buys mean high expectations. Read the guide: What analyst ratings and price targets tell you.

Earnings

The next report is on the calendar for 26 October 2026 for Q3 2026, with earnings per share expected at $1.29. The last report, on 4 August 2026 for Q2 2026, showed EPS of $1.41 against $1.22 expected, a beat of 15.6%, on revenue of $729.7 million. Revvity, Inc. beat the EPS estimate in 8 of its last 8 reported quarters.

Set a percent move alert before the report and the app pings you when the stock reacts, even after hours: open RVTY in Just Stock Quotes.

The numbers

Over the trailing twelve months Revvity, Inc. shows revenue growth of N.A., a gross margin of N.A., an operating margin of N.A. and a return on equity of N.A..

Margins say how much of each dollar of sales becomes profit, returns say how hard the balance sheet works, and debt to equity says how much of it is borrowed. The valuation ratios, price to earnings and the rest, are in the app on the stock page. Read the guide: The valuation ratios on a stock page.

About Revvity, Inc.

Exchange

NYSE

Sector

Health Care

Industry

Measuring And Control Equipment

Headquarters

Boston, Massachusetts

Chief executive

Prahlad R. Singh

Employees

16,700

Website

perkinelmer.com

Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

In the same sector

Other Health Care names in the S&P 500, by market cap:

LLY Eli Lilly & Co.JNJ Johnson & JohnsonABBV AbbVie Inc.MRK Merck & Co. Inc.UNH UnitedHealth Group Inc.TMO Thermo Fisher Scientific Inc.AMGN Amgen Inc.GILD Gilead Sciences, Inc.

Learn

• How to read a stock quote
• Reading a price chart from one day to one year
• Moving averages, the 52 week range and beta
• What analyst ratings and price targets tell you
• The valuation ratios on a stock page
• Price alerts, targets and percent moves